Patient preferences for anti-hyperglycaemic medication for type 2 diabetes mellitus in China: findings from a national survey.

Patients with T2DM prioritised free out-of-pocket costs, highest efficacy, no hypoglycaemia risk and cardiovascular benefits over weight change and mode of administration. There exists great preference heterogeneity among patients, which should be taken into account in healthcare decision-making processes.